MULTIPLE USE OF SINGLE-USE PRODUCT

This adverse event was reported 5620 times

These drugs are most commonly taken by patients reporting MULTIPLE USE OF SINGLE-USE PRODUCT:

# Drug Count
0 ONABOTULINUMTOXINA 2866
1 CYCLOSPORINE 741
2 INSULIN GLARGINE 439
3 SOMATROPIN 132
4 AFLIBERCEPT 119
5 TESTOSTERONE CYPIONATE 115
6 ORITAVANCIN DIPHOSPHATE 109
7 ACOLTREMON 96
8 ORAL SEMAGLUTIDE 79
9 METFORMIN 75
See all common drugs associated with MULTIPLE USE OF SINGLE-USE PRODUCT

MULTIPLE USE OF SINGLE-USE PRODUCT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ORITAVANCIN DIPHOSPHATE 109 0.3670
1 MEBROFENIN 29 0.3152
2 SINCALIDE 29 0.1895
3 ONABOTULINUMTOXINA 2866 0.0368
4 ORITAVANCIN 30 0.0326
5 CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 14 0.0252
6 BALANCED SALT SOLUTION 22 0.0170
7 OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC 38 0.0161
8 DIFLUPREDNATE OPHTHALMIC 14 0.0158
9 ACOLTREMON 96 0.0152
See all drugs enriched for association with MULTIPLE USE OF SINGLE-USE PRODUCT

MULTIPLE USE OF SINGLE-USE PRODUCT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholecystokinin Analog [EPC] 29 0.1895
1 Acetylcholine Release Inhibitor [EPC] 2869 0.0289
2 TRPM8 Thermoreceptor Agonist [EPC] 96 0.0152
3 Interferon gamma [EPC] 11 0.0078
4 Calcineurin Inhibitor Immunosuppressant [EPC] 743 0.0057
5 Recombinant Human Growth Hormone [EPC] 119 0.0054
6 Antiseptic [EPC] 19 0.0043
7 PCSK9 Inhibitor [EPC] 59 0.0023
8 Antiparasitic [EPC] 10 0.0022
9 Semifluorinated Alkane [EPC] 5 0.0022
See all drug classes enriched for association with MULTIPLE USE OF SINGLE-USE PRODUCT